Skip to main content

and
  1. Article

    Open Access

    Combination treatment with 2-methoxyestradiol overcomes bortezomib resistance of multiple myeloma cells

    Bortezomib is a proteasome inhibitor used for the treatment of relapsed/refractory multiple myeloma (MM). However, intrinsic and acquired resistance to bortezomib has already been observed in MM patients. In a...

    In-Sung Song, Yu Jeong Jeong, Seung Hun Jeong in Experimental & Molecular Medicine (2013)